HHCP
ELV icon

Hilton Head Capital Partners’s Elevance Health ELV Stock Holding History

Hilton Head Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
1,011
-30
-3% -$11.1K 0.2% 116
2026
Q1 		$305K Hold
1,041
– – 0.17% 116
2025
Q4 		$365K Buy
+1,041
New +$352K 0.21% 104

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hilton Head Capital Partners's ELV Position: Q2 2026 in Review

Hilton Head Capital Partners reduced its Elevance Health (ELV) stake by 2.9% in Q2 2026, selling an estimated $11.1K and leaving 1,011 shares worth $391K. The position accounts for 0.2% of the portfolio, ranked #116.

Hilton Head Capital Partners first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hilton Head Capital Partners held 1,011 shares of Elevance Health worth $391K as of Q2 2026.
  • Hilton Head Capital Partners sold 30 Elevance Health shares in Q2 2026, an estimated $11.1K.
  • Elevance Health made up 0.2% of Hilton Head Capital Partners's portfolio in Q2 2026, its #116 holding.
  • Hilton Head Capital Partners first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.